查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087409

即時檢測市場：2026-2032年全球市場預測（按產品類型、檢測類型、檢體類型、技術、便攜性、購買方式、應用、最終用戶和分銷管道分類）

Point of Care Testing Market by Product, Test Type, Sample Type, Technology, Portability, Mode of Purchase, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，即時檢測市場規模將達到 907.6 億美元，複合年成長率為 13.61%。

主要市場統計數據
基準年 2025 371.3億美元
預計年份：2026年 419.9億美元
預測年份 2032 907.6億美元
複合年成長率 (%) 13.61%

即時檢測（POC​​T）正在改變我們的診斷方式，使臨床可用的檢測結果能夠更便捷地送達患者手中，無論是在醫院、診所、藥房、救護車、職場或家中。該領域涵蓋血糖值監測、傳染病檢查、心臟標記檢測、血液凝固檢驗、血氣和電解質分析、懷孕和不孕症檢測、尿液檢查以及新興的分子和多參數診斷平台。

需求的促進因素是醫療保健系統面臨的許多挑戰，包括人口老化、慢性病盛行率上升、抗生素抗藥性、分散式醫療模式以及加速臨床決策的需求。美國食品藥物管理局(FDA) 等監管機構的監管，以及《臨床實驗室改進修正案》(CLIA)、歐盟體外醫療設備法規和世界衛生組織 (WHO)《基本診斷指南》等框架，持續影響醫療品質、安全性、可近性和分銷。

POCT領域的變革性變化

即時檢測 (POCT) 的格局正在從單次分析、依賴操作人員的設備轉向聯網、品管和數據整合的診斷生態系統。檢查室和醫療網路在評估即時偵測設備時，不僅關注速度，還越來越重視分析效能、互通性、網路安全、操作人員培訓、可追溯性和整體擁有成本。

人工智慧在即時檢測（POC​​T）領域的累積影響

人工智慧 (AI) 透過自動影像解讀、訊號分析、決策支援、品質監控和工作流程最佳化，對即時檢測 (POCT) 產生日益顯著的影響。借助 AI 技術，操作人員可以減少側向流動檢測判斷中的主觀性，提高數位顯微鏡的模式識別能力，並透過處理來自聯網儀器的數據，幫助檢測異常結果、儀器漂移或操作人員失誤。

主要區域洞察：亞太地區、北美地區、歐洲、拉丁美洲、中東和非洲

北美擁有成熟的即時檢測環境，醫療費用支出、美國CLIA豁免檢測框架、慢性病管理項目、對緊急醫療服務的需求，以及透過急診診所和零售醫療機構提供的廣泛服務。歐洲的特點是醫療保健優先事項分散、人口老化、合理使用抗生素，以及歐盟體外診斷醫療設備法規（IVDR），該法規提高了對診斷設備製造商的證據要求，並加強了上市後監管的作用。在亞太地區，中國、印度、日本、澳洲、韓國和東南亞國協的市場正透過醫院現代化、感染疾病監測、糖尿病管理、老年相關護理以及基層醫療的普及而不斷擴張。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

在七國集團（G7）國家中，即時檢測（POC​​T）的普及與以價值為導向的醫療、急診科效率的提升、慢性病監測、合理使用抗生素以及監管機構對循證醫學和品質體系的重視密切相關。歐盟則深受體外診斷醫療器材法規（ 管治 ）、採購標準、檢查室管理以及跨境醫療保健優先事項的影響，這些因素都提升了臨床證據、上市後監測和互通性報告的重要性。

來自主要POCT市場關鍵國家的洞察

美國在廣泛應用CLIA豁免檢測、拓展零售醫療保健、分散式檢查模式以及在FDA監管下進行診斷技術創新方面主導，而加拿大則專注於確保廣大地區的醫療服務可及性、提供遠端醫療以及與省級醫療保健系統整合。在墨西哥和巴西，無論是在公共醫療機構還是私人醫療機構，對價格合理、快速的檢測，特別是感染疾病檢測、妊娠檢測和慢性病監測的需求都持續存在。在歐洲，英國、德國、法國、義大利和西班牙優先考慮提高醫院效率、普及基層醫療、管理慢性病、合理使用抗生素以及遵守更嚴格的體外診斷（IVD）法規，而俄羅斯則在其廣袤的國土上保持著對社區診斷和分散式醫療保健服務的需求。

為POCT行業領導者提供的實用建議

產業領導者應優先考慮經過臨床檢驗的即時檢測平台，這些平台應具備準確性、易用性、連接性、可追溯性以及對工作流程的可衡量影響。產品策略必須與實際臨床流程相契合，例如急診分流、合理使用抗生素、糖尿病管理、心血管風險評估、呼吸道傳染病檢查、孕產婦健康管理和遠端患者監護監護。

調查方法

本執行摘要基於二手研究和對公開權威資訊來源的分析整合，這些資料包括健康指南、法律規範、同行評審文獻、臨床實踐趨勢、國際醫療保健系統優先事項和公共衛生項目。主要參考點包括美國食品藥物管理局 (FDA) 對體外診斷醫療設備和醫療設備軟體的監管、臨床實驗室改進修正案 (CLIA) 的要求、歐盟體外醫療設備法規 (IVDR) 的實施、世界衛生組織 (WHO) 的診斷指南以及應對感染疾病、慢性病管理和分散式醫療保健的全球舉措。

結論

即時檢測正逐漸成為現代診斷的核心要素，因為它能縮短臨床干預時間、支持分散式醫療、改善分流並加強疾病監測。當它與速度、分析可靠性、協調的數據收集、品管、操作人員培訓和清晰的臨床方案相結合時，其價值才能最大程度地發揮出來。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 即時檢測市場：依產品分類

  • 耗材、服務和軟體
    • 耗材和配件
    • 維護和校準服務
    • 軟體和連接性
  • 儀器/分析儀
    • 桌上型分析儀
    • 分子診斷平台
    • 可攜式分析儀
    • 閱讀器和掃描儀
  • 試劑和測定
    • 血糖試紙
    • 血液檢測試劑
    • 免疫檢測試劑
    • 橫向流動化驗試劑
    • 分子診斷試劑盒

第8章 即時檢測市場：依檢測類型分類

  • 血氣分析
  • 心臟標記物
    • B型鈉尿肽
    • 肌鈣蛋白
  • 綜合代謝指標
  • 藥物濫用檢測
  • 血液學
    • 血液凝固檢驗
      • 活化部份凝血活酵素時間
      • 纖維蛋白原濃度
      • 凝血酶原時間與國際標準化比值
    • 血液常規檢查
  • 感染疾病
    • 胃腸道傳染病檢查
    • 呼吸道傳染病檢查
    • 性行為感染感染檢測
  • 分子診斷
  • 妊娠和不孕症治療
  • 尿液檢查

第9章 即時檢測市場：依樣本類型分類

  • 血
  • 鼻腔和棉花棒檢體
  • 唾液
  • 尿

第10章：即時偵測市場：依技術分類

  • 電化學生物感測器
  • 比色測量平台
  • 免疫檢測
  • 橫向流動化驗
    • 抗體檢測
    • 抗原檢測
    • 多重側流
  • 微流體技術
  • PCR和分子診斷

第11章 即時偵測市場：依便攜性分類

  • 桌上型固定分析儀
  • 可攜式手持設備

第12章 即時偵測市場：依購買方式分類

  • 市售檢測套組
  • 處方箋檢測

第13章 即時偵測市場：依應用領域分類

  • 慢性病管理
  • 緊急和緊急醫療
  • 感染疾病診斷
  • 職業和職場測試
  • 腫瘤監測
  • 女性健康

第14章 即時偵測市場：依最終用戶分類

  • 門診部
  • 診斷檢查室
  • 獨立急診診所
  • 居家照護
  • 醫院和診所
  • 急診中心

第15章 即時偵測市場：依通路分類

  • 離線
    • 直銷
    • 銷售代理商和批發商
    • 零售和藥房
  • 線上

第16章 即時偵測市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第17章 即時偵測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第18章 即時偵測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第20章：公司簡介

  • Abaxis, Inc. by Zoetis Inc
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • CardioGenics Holdings Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • Danaher Corporation
  • EKF Diagnostics Holdings
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare Technologies, Inc.
  • Medtronic Plc
  • Nova Biomedical Corporation
  • OraSure Technologies, Inc.
  • Quidel Corporation
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-035AB9C0DA8B

The Point of Care Testing Market is projected to grow by USD 90.76 billion at a CAGR of 13.61% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 37.13 billion
Estimated Year [2026] USD 41.99 billion
Forecast Year [2032] USD 90.76 billion
CAGR (%) 13.61%

Point of care testing (POCT) is reshaping diagnostics by moving clinically actionable results closer to patients in hospitals, clinics, retail pharmacies, ambulances, workplaces, and homes. The category spans blood glucose monitoring, infectious disease testing, cardiac markers, coagulation, blood gas and electrolyte testing, pregnancy and fertility testing, urinalysis, and emerging molecular and multiplex diagnostic platforms.

Demand is supported by well-documented pressures on health systems, including aging populations, rising chronic disease prevalence, antimicrobial resistance, decentralized care models, and the need for faster clinical decisions. Regulatory oversight from agencies such as the U.S. Food and Drug Administration and frameworks such as Clinical Laboratory Improvement Amendments, the European Union In Vitro Diagnostic Regulation, and World Health Organization essential diagnostics guidance continue to shape quality, safety, access, and adoption.

Transformative Shifts in the POCT Landscape

The POCT landscape is shifting from single-analyte, operator-dependent devices toward connected, quality-controlled, and data-integrated diagnostic ecosystems. Laboratories and care networks increasingly evaluate point of care devices not only for speed, but also for analytical performance, interoperability, cybersecurity, operator training, traceability, and total cost of ownership.

COVID-19 accelerated public familiarity with rapid testing and demonstrated the operational value of decentralized diagnostics for triage, surveillance, and continuity of care. At the same time, reimbursement scrutiny, supply-chain resilience, and stricter in vitro diagnostic regulations are pushing manufacturers to validate performance across diverse populations and real-world settings. The competitive focus is moving toward platforms that combine usability, connectivity, quality assurance, and clinically meaningful turnaround time.

Cumulative Impact of Artificial Intelligence in POCT

Artificial intelligence is increasingly influencing point of care testing through automated image interpretation, signal analysis, decision support, quality monitoring, and workflow optimization. AI-enabled readers can help reduce subjectivity in lateral flow test interpretation, improve pattern recognition in digital microscopy, and flag anomalous results, device drift, or operator errors when paired with connected device data.

The cumulative impact is not only faster interpretation but also more consistent performance at distributed testing sites. However, AI adoption in POCT depends on transparent validation, bias assessment, clinical governance, cybersecurity, human oversight, and compliance with evolving medical device software regulations. Industry leaders must treat AI as a regulated clinical capability rather than a marketing layer.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

North America remains a mature point of care testing environment, supported by high healthcare spending, CLIA-waived testing pathways in the United States, chronic disease management programs, emergency care demand, and wide access through urgent care and retail health settings. Europe is shaped by decentralized care priorities, aging populations, antimicrobial stewardship, and the EU IVDR, which raises evidence expectations for diagnostic manufacturers and strengthens the role of post-market surveillance. Asia-Pacific is expanding through hospital modernization, infectious disease surveillance, diabetes management, aging-related care, and broader primary care access across China, India, Japan, Australia, South Korea, and ASEAN economies.

Latin America shows rising demand for rapid infectious disease, pregnancy, and chronic disease testing, although reimbursement variability, infrastructure gaps, and uneven laboratory access affect adoption. Middle East markets benefit from hospital investment, national health transformation programs, digital health initiatives, and demand for rapid emergency diagnostics. Africa relies heavily on POCT for HIV, malaria, tuberculosis, maternal health, antimicrobial stewardship, and outbreak response, with adoption tied to affordability, supply continuity, training, power reliability, and connectivity in low-resource settings.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Across G7 countries, point of care testing adoption is closely linked to value-based care, emergency department efficiency, chronic disease monitoring, antimicrobial stewardship, and regulatory emphasis on evidence and quality systems. The European Union is strongly influenced by IVDR implementation, procurement standards, laboratory governance, and cross-border healthcare priorities, increasing the importance of clinical evidence, post-market surveillance, and interoperable reporting.

BRICS economies are important demand centers because of large patient populations, public health screening needs, infectious disease burdens, and expanding domestic diagnostic manufacturing. ASEAN countries are prioritizing primary care access, maternal and child health, noncommunicable disease management, and infectious disease readiness, while GCC markets are investing in high-acuity hospital infrastructure, emergency medicine, and digital health transformation. NATO members also emphasize deployable diagnostics for military medicine, emergency preparedness, field triage, and resilient health security systems.

Key Country Insights Across Major POCT Markets

The United States leads through broad clinical use of CLIA-waived tests, retail health expansion, decentralized testing models, and FDA-regulated diagnostic innovation, while Canada emphasizes access across large geographies, remote care delivery, and provincial health system integration. Mexico and Brazil show sustained demand for affordable rapid tests in public and private care, especially for infectious diseases, pregnancy testing, and chronic disease monitoring. In Europe, the United Kingdom, Germany, France, Italy, and Spain prioritize hospital efficiency, primary care access, chronic disease management, antimicrobial stewardship, and compliance with stricter IVD rules, while Russia maintains demand for localized diagnostics and distributed healthcare access across broad territories.

In Asia-Pacific, China is expanding domestic diagnostic capacity, hospital-based testing, infectious disease surveillance, and chronic disease management; India relies on POCT to extend access across tiered healthcare settings, rural clinics, pharmacies, and public health programs; and Japan emphasizes quality, aging-related care, emergency diagnostics, and advanced testing technologies. Australia supports POCT in remote and Aboriginal health services, emergency care, and chronic disease programs, while South Korea combines strong diagnostics manufacturing, hospital digitalization, and connected healthcare adoption.

Actionable Recommendations for POCT Industry Leaders

Industry leaders should prioritize clinically validated point of care testing platforms that demonstrate accuracy, usability, connectivity, traceability, and measurable workflow impact. Product strategies should align with real care pathways such as emergency triage, antimicrobial stewardship, diabetes management, cardiovascular risk assessment, respiratory infection testing, maternal health, and remote patient monitoring.

Manufacturers should invest in interoperability with electronic health records, operator lockout and quality control features, cybersecurity, data governance, and cloud-based fleet management. Commercial teams need region-specific evidence packages that address reimbursement, procurement, regulatory requirements, training capacity, and public health priorities. Partnerships with laboratories, pharmacies, primary care networks, hospitals, public health agencies, and telehealth providers can accelerate adoption while maintaining governance, quality, and clinical accountability.

Research Methodology

This executive summary is based on secondary research and analytical synthesis from publicly available, authoritative sources, including health agency guidance, regulatory frameworks, peer-reviewed literature, clinical practice trends, international health system priorities, and public health programs. Key reference points include FDA oversight of in vitro diagnostics and medical device software, CLIA requirements, EU IVDR implementation, WHO diagnostics guidance, and global initiatives addressing infectious diseases, chronic disease management, and decentralized care.

Insights were evaluated through a market-structure lens covering clinical need, technology readiness, regulatory requirements, procurement behavior, geographic access, health system infrastructure, quality assurance, and competitive differentiation. No unverified market-size figures, market share claims, or unsupported growth forecasts are used.

Conclusion

Point of care testing is becoming a core component of modern diagnostics because it reduces time to clinical action, supports decentralized care, improves triage, and strengthens disease surveillance. Its value is highest when speed is matched by analytical reliability, connected data capture, quality controls, operator training, and clear clinical protocols.

The next phase of POCT competition will favor organizations that integrate validated assays, AI-enabled interpretation, secure connectivity, interoperable reporting, and region-specific commercialization strategies. Stakeholders that balance innovation with regulatory rigor, affordability, and real-world usability will be best positioned to serve hospitals, community care, public health, emergency medicine, and home-based testing environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Point of Care Testing Market, by Product

  • 7.1. Consumables Services & Software
    • 7.1.1. Consumables & Accessories
    • 7.1.2. Service Maintenance & Calibration
    • 7.1.3. Software & Connectivity
  • 7.2. Instruments & Analyzers
    • 7.2.1. Benchtop Analyzers
    • 7.2.2. Molecular Platforms
    • 7.2.3. Portable Analyzers
    • 7.2.4. Readers & Scanners
  • 7.3. Reagents & Assays
    • 7.3.1. Glucose Test Strips
    • 7.3.2. Hematology Reagents
    • 7.3.3. Immunoassay Reagents
    • 7.3.4. Lateral Flow Assay Reagents
    • 7.3.5. Molecular Assay Kits

8. Point of Care Testing Market, by Test Type

  • 8.1. Blood Gases
  • 8.2. Cardiac Markers
    • 8.2.1. B-type Natriuretic Peptide
    • 8.2.2. Troponin
  • 8.3. Comprehensive Metabolic Panel
  • 8.4. Drug Of Abuse Testing
  • 8.5. Hematology
    • 8.5.1. Coagulation Tests
      • 8.5.1.1. Activated Partial Thromboplastin Time
      • 8.5.1.2. Fibrinogen Level
      • 8.5.1.3. Prothrombin Time & International Normalized Ratio
    • 8.5.2. Complete Blood Count
  • 8.6. Infectious Disease
    • 8.6.1. Gastrointestinal Infection Tests
    • 8.6.2. Respiratory Infection Tests
    • 8.6.3. Sexually Transmitted Infection Tests
  • 8.7. Molecular Diagnostics
  • 8.8. Pregnancy & Fertility
  • 8.9. Urinalysis

9. Point of Care Testing Market, by Sample Type

  • 9.1. Blood
  • 9.2. Nasal & Swab Samples
  • 9.3. Saliva
  • 9.4. Urine

10. Point of Care Testing Market, by Technology

  • 10.1. Biosensor Electrochemical
  • 10.2. Colorimetric Platforms
  • 10.3. Immunoassay
  • 10.4. Lateral Flow Assays
    • 10.4.1. Antibody Tests
    • 10.4.2. Antigen Tests
    • 10.4.3. Multiplex Lateral Flow
  • 10.5. Microfluidics
  • 10.6. PCR And Molecular

11. Point of Care Testing Market, by Portability

  • 11.1. Benchtop Fixed Analyzers
  • 11.2. Portable Handheld Devices

12. Point of Care Testing Market, by Mode of Purchase

  • 12.1. Over-The-Counter Tests
  • 12.2. Prescription-Based Tests

13. Point of Care Testing Market, by Application

  • 13.1. Chronic Disease Management
  • 13.2. Emergency And Critical Care
  • 13.3. Infectious Disease Diagnosis
  • 13.4. Occupational And Workplace Testing
  • 13.5. Oncology Monitoring
  • 13.6. Women Health

14. Point of Care Testing Market, by End User

  • 14.1. Ambulatory Care Centers
  • 14.2. Diagnostic Laboratories
  • 14.3. Free-Standing Emergency Departments
  • 14.4. Home Care
  • 14.5. Hospitals & Clinics
  • 14.6. Urgent Care Centers

15. Point of Care Testing Market, by Distribution Channel

  • 15.1. Offline
    • 15.1.1. Direct Sales
    • 15.1.2. Distributor & Wholesale
    • 15.1.3. Retail & Pharmacy
  • 15.2. Online

16. Point of Care Testing Market, by Region

  • 16.1. Asia-Pacific
  • 16.2. North America
  • 16.3. Latin America
  • 16.4. Europe
  • 16.5. Middle East
  • 16.6. Africa

17. Point of Care Testing Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. Point of Care Testing Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025

20. Company Profiles

  • 20.1. Abaxis, Inc. by Zoetis Inc
  • 20.2. Abbott Laboratories
  • 20.3. AccuBioTech Co., Ltd.
  • 20.4. ACON Laboratories, Inc.
  • 20.5. Beckman Coulter
  • 20.6. Becton, Dickinson and Company
  • 20.7. Bio-Rad Laboratories, Inc.
  • 20.8. bioMerieux SA
  • 20.9. CardioGenics Holdings Inc.
  • 20.10. Chembio Diagnostic Systems, Inc. by Biosynex
  • 20.11. Danaher Corporation
  • 20.12. EKF Diagnostics Holdings
  • 20.13. F. Hoffmann-La Roche Ltd
  • 20.14. GE Healthcare Technologies, Inc.
  • 20.15. Medtronic Plc
  • 20.16. Nova Biomedical Corporation
  • 20.17. OraSure Technologies, Inc.
  • 20.18. Quidel Corporation
  • 20.19. Radiometer Medical ApS
  • 20.20. Randox Laboratories Ltd.
  • 20.21. Siemens Healthineers AG
  • 20.22. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POINT OF CARE TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL POINT OF CARE TESTING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 31. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMABLES SERVICES & SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES SERVICES & SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES SERVICES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SERVICE MAINTENANCE & CALIBRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SERVICE MAINTENANCE & CALIBRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SERVICE MAINTENANCE & CALIBRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SOFTWARE & CONNECTIVITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SOFTWARE & CONNECTIVITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SOFTWARE & CONNECTIVITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BENCHTOP ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BENCHTOP ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BENCHTOP ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL READERS & SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL READERS & SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL READERS & SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REAGENTS & ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REAGENTS & ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REAGENTS & ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEMATOLOGY REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEMATOLOGY REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEMATOLOGY REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMMUNOASSAY REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IMMUNOASSAY REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMMUNOASSAY REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LATERAL FLOW ASSAY REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LATERAL FLOW ASSAY REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LATERAL FLOW ASSAY REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MOLECULAR ASSAY KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MOLECULAR ASSAY KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MOLECULAR ASSAY KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD GASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD GASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD GASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC MARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC MARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC MARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL B-TYPE NATRIURETIC PEPTIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL B-TYPE NATRIURETIC PEPTIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL B-TYPE NATRIURETIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TROPONIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TROPONIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TROPONIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPREHENSIVE METABOLIC PANEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COMPREHENSIVE METABOLIC PANEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPREHENSIVE METABOLIC PANEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COAGULATION TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COAGULATION TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COAGULATION TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ACTIVATED PARTIAL THROMBOPLASTIN TIME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ACTIVATED PARTIAL THROMBOPLASTIN TIME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ACTIVATED PARTIAL THROMBOPLASTIN TIME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FIBRINOGEN LEVEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FIBRINOGEN LEVEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FIBRINOGEN LEVEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL COMPLETE BLOOD COUNT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPLETE BLOOD COUNT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL COMPLETE BLOOD COUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL INFECTION TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL INFECTION TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL INFECTION TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESPIRATORY INFECTION TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESPIRATORY INFECTION TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESPIRATORY INFECTION TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SEXUALLY TRANSMITTED INFECTION TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SEXUALLY TRANSMITTED INFECTION TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SEXUALLY TRANSMITTED INFECTION TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PREGNANCY & FERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PREGNANCY & FERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PREGNANCY & FERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL URINALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL URINALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NASAL & SWAB SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NASAL & SWAB SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NASAL & SWAB SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOSENSOR ELECTROCHEMICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOSENSOR ELECTROCHEMICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIOSENSOR ELECTROCHEMICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL COLORIMETRIC PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL COLORIMETRIC PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL COLORIMETRIC PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANTIBODY TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTIBODY TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANTIBODY TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTIGEN TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANTIGEN TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTIGEN TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MULTIPLEX LATERAL FLOW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MULTIPLEX LATERAL FLOW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MULTIPLEX LATERAL FLOW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MICROFLUIDICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PCR AND MOLECULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PCR AND MOLECULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PCR AND MOLECULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BENCHTOP FIXED ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BENCHTOP FIXED ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BENCHTOP FIXED ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL OVER-THE-COUNTER TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL OVER-THE-COUNTER TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL OVER-THE-COUNTER TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PRESCRIPTION-BASED TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PRESCRIPTION-BASED TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PRESCRIPTION-BASED TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL EMERGENCY AND CRITICAL CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL EMERGENCY AND CRITICAL CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL EMERGENCY AND CRITICAL CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL OCCUPATIONAL AND WORKPLACE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL OCCUPATIONAL AND WORKPLACE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL OCCUPATIONAL AND WORKPLACE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ONCOLOGY MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ONCOLOGY MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ONCOLOGY MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL WOMEN HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL WOMEN HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL WOMEN HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL FREE-STANDING EMERGENCY DEPARTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL FREE-STANDING EMERGENCY DEPARTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL FREE-STANDING EMERGENCY DEPARTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL URGENT CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL URGENT CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL URGENT CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL DISTRIBUTOR & WHOLESALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL DISTRIBUTOR & WHOLESALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL DISTRIBUTOR & WHOLESALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL RETAIL & PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL RETAIL & PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL RETAIL & PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 254. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 256. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 258. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 302. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 306. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 310. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 311. AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 313. AFRICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 314. AFRICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 315. AFRICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 316. AFRICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. AFRICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
  • TABLE 318. AFRICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 319. AFRICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 320. AFRICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 321. AFRICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. AFRICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 323. AFRICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 324. AFRICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 325. AFRICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 326. AFRICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 327. AFRICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. AFRICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 329. AFRICA POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 330. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 331. ASEAN POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 332. ASEAN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 333. ASEAN POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 334. ASEAN POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 335. ASEAN POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 336. ASEAN POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. ASEAN POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
  • TABLE 338. ASEAN POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 339. ASEAN POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
  • TABLE 340. ASEAN POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 341. ASEAN POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. ASEAN POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 343. ASEAN POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 344. ASEAN POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 345. ASEAN POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 346. ASEAN POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 347. ASEAN POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 348. ASEAN POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 349. ASEAN POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 350. GCC POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 351. GCC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 352. GCC POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 353. GCC POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 354. GCC POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 355. GCC POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 356. GCC POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
  • TABLE 357. GCC POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 358. GCC POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD